Predictive Technology Group, Inc.

Business Description

Predictive Technology Group, Inc. (PRED) through its wholly owned subsidiary Predictive Therapeutics, Inc. revolutionizes the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. The Company has developed and/or acquired a number of proprietary technologies that open a window into the origin of human disease and the role that genes and their related proteins play in the disease’s onset and progression. PRED uses this information as the cornerstone in the development of new diagnostics that assess a person’s risk of disease and therapeutic products designed to effectively prevent and/or treat the disease.



Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Audited Financials Unaudited
Latest Report Sept. 30, 2017 – Quarterly Report
CIK 0001382943
Fiscal Year End 06/30
OTC Marketplace OTC Pink Current
Profile Data
SIC – Industry Classification 2835 – Diagnostic substances
Business Status Development Stage Company a/o Sep 16, 2008
Incorporated In: NV, USA
Year of Inc. 2005
Employees 27 a/o Oct. 31, 2017
Company Officers/Contacts
Mel Fergusen Secretary, Treasurer
Bradley Robinson President
Company Directors
Mel Fergusen Chairman
Bradley Robinson  Director

Service Providers

Investor Relations Firm

LHA Investor Relations
2121 Avenue of the Stars
Suite 2970
Los Angeles, CA 90067
United States
Phone: 310-691-7100

PCAOUB Auditing Firm

Sadler, Gibb & Associates, LLC

2455 E. Parleys Way Suite 320
Salt Lake City, UT, 84109 United States

Accounting Firm

CS&S Enterprises
5840 West Craig Road
Las Vegas, NV, 89130
United States

Securities – Legal

Law Office of Robert W. Wright
716 Castro St.
Solana Beach, CA, 92075
United States

Intellectual Properties – Legal

Wilson Sonsini Goodrich & Rosati

650 Page Mill Road
Palo Alto, CA 94304-1050

Phone: 650-493-9300